Associate Director, Business Development and Transactions jobs in United States
cer-icon
Apply on Employer Site
company-logo

Insmed Incorporated · 1 day ago

Associate Director, Business Development and Transactions

Insmed Incorporated is a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases. They are seeking an Associate Director, Business Development and Transactions to support the development and execution of growth strategies and to evaluate, value, structure, and negotiate business opportunities including acquisitions and strategic alliances.

BiotechnologyMedicalPharmaceutical
check
Growth Opportunities

Responsibilities

Lead the evaluation of scientific and data-driven analyses and prepare written/oral summaries/presentations of the uncovered information related to new product in-licensing, acquisitions, or merger
Support the diligence plans required to evaluate and complete transactions
Help coordinate and direct the business cross functional team as well as external advisor relationships (investment banks, law firms, accounting firms) according to agreed diligence plan
Support and conduct strategic, market, competitive, and financial analyses of business development opportunities, including potential acquisitions, divestitures, alliances and strategic investments
Maintain databases of opportunities and historical records of previous evaluations
Establish external and internal networks to support market intelligence and identification of relevant business transformation opportunities for growth
Foster strong cross-functional collaboration with teams such as Commercial, Market Access, Sales, Research, Clinical, Regulatory, CMC, Finance, and Legal
Attend external partnering and scientific conferences and meetings

Qualification

Business DevelopmentCorporate FinanceNegotiationMarket AnalysisLife Sciences ExperienceProject ManagementCommunication SkillsLeadership SkillsInterpersonal SkillsProblem-Solving Skills

Required

Bachelor's degree
3+ years of business experience (preferably in the Pharma/Biotech BD groups or corporate Finance)
5+ years of experience in the life sciences, medical, or health care industry
Exceptional knowledge of disease areas, drug development activities, and commercial processes
Strong understanding of corporate finance, modeling, and deep project management skills
Experience structuring, negotiating, and closing business development-related transactions
Experience working in a matrixed team environment with ability to collaborate effectively with colleagues and external partners
Ability to partner with attorneys and other deal professionals in developing and evolving transaction structures, integrating due diligence findings, and driving successful negotiation outcomes
Experience in presenting recommendations and influencing internal and external groups
Excellent communication (both written and verbal), leadership, interpersonal, and problem-solving skills

Preferred

Degree focused on Biology, Cell Biology, Neurology, or other related discipline

Benefits

Comprehensive medical, dental, and vision coverage and mental health support, annual wellbeing reimbursement, and access to our Employee Assistance Program (EAP)
Generous paid time off policies, fertility and family-forming benefits, caregiver support, and flexible work schedules with purposeful in-person collaboration
401(k) plan with a competitive company match, annual equity awards, and participation in our Employee Stock Purchase Plan (ESPP), and company-paid life and disability insurance
Company Learning Institute providing access to LinkedIn Learning, skill building workshops, leadership programs, mentorship connections, and networking opportunities
Employee resource groups, service and recognition programs, and meaningful opportunities to connect, volunteer, and give back

Company

Insmed Incorporated

twittertwittertwitter
company-logo
Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases.

Funding

Current Stage
Public Company
Total Funding
$4.56B
Key Investors
CureDuchenne Ventures
2025-06-11Post Ipo Equity· $750M
2024-05-30Post Ipo Equity· $650M
2023-05-08Post Ipo Equity· $0.5M

Leadership Team

leader-logo
Will Lewis
Chairman and Chief Executive officer
linkedin
leader-logo
Walter R. Perkins
Chief Technology Officer
linkedin
Company data provided by crunchbase